Alembic Pharma reports stellar numbers for Q2FY16

27 Oct 2015 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2015.

The company has over three fold jump in its net profit after tax at Rs 252.67 crore for the quarter ended September 30, 2015 as compared to Rs 84.05 crore for the same quarter in the previous year. The company’s total income has increased by 70.37% to Rs 922.59 crore for the quarter under review from Rs 541.52 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported over three fold jump in its net profit/(loss) after tax and share of profit of associates at Rs 288.90 crore for the quarter ended September 30, 2015 as compared to Rs 77.27 crore for the same quarter in the previous year. Total income of the company has increased by 84.35% at Rs 1008.81 crore for quarter under review as compared to Rs 547.22 crore for the quarter ended September 30, 2014. 

 

Alembic Pharma Share Price

880.60 -19.30 (-2.14%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×